Incidence of COVID-19 in a cohort of dermatology patients receiving immunomodulating biologic medications. Alamgir, M., Jamgochian, M., Cucalon, J., Razi, S., Farabi, B., & Rao, B. International Journal of Dermatology, 60(12):e500–e501, December, 2021.
Incidence of COVID-19 in a cohort of dermatology patients receiving immunomodulating biologic medications [link]Paper  doi  bibtex   
@article{alamgir_incidence_2021,
	title = {Incidence of {COVID}-19 in a cohort of dermatology patients receiving immunomodulating biologic medications},
	volume = {60},
	copyright = {All rights reserved},
	issn = {1365-4632},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/34590713},
	doi = {10.1111/ijd.15922},
	language = {eng},
	number = {12},
	journal = {International Journal of Dermatology},
	author = {Alamgir, Mahin and Jamgochian, Marielle and Cucalon, Jennifer and Razi, Shazli and Farabi, Banu and Rao, Babar},
	month = dec,
	year = {2021},
	pages = {e500--e501},
}

Downloads: 0